Compare Cemex S.A.B. de C.V. Sponsored ADR (CX) vs Immunovant Inc. Common Stock (IMVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cemex S.A.B. de C.V. Sponsored ADR vs Immunovant Inc. Common Stock — how do they compare? Cemex S.A.B. de C.V. Sponsored ADR trades at $9.46 (market cap $13.79B), while Immunovant Inc. Common Stock trades at $30.41 (market cap $6.25B). The key difference: Cemex S.A.B. de C.V. Sponsored ADR is far larger — about 2.2× Immunovant Inc. Common Stock's market cap, and Cemex S.A.B. de C.V. Sponsored ADR pays a 1.3% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cemex S.A.B. de C.V. Sponsored ADR for 0 Days and Immunovant Inc. Common Stock for 0 Days on average.
| CX | IMVT | |
|---|---|---|
Market Cap | $13.79B | $6.25B |
Volume | 3,993,982 | 1,755,411 |
Sector | Basic Materials | Health |
52-Week High | $13.55 | $44.96 |
52-Week Low | $9.12 | $17.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $19.79B | $5.35B |
Dividend Yield | 1.3% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cemex S.A.B. de C.V. Sponsored ADR
Cemex produces, distributes, markets, and sells cement, ready-mix concrete, aggregates, and other construction materials. Its operations serve markets around the world.
Read more on CX →About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →
